Viewing Study NCT07149467


Ignite Creation Date: 2025-12-25 @ 12:46 AM
Ignite Modification Date: 2026-04-03 @ 6:54 AM
Study NCT ID: NCT07149467
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-02
First Post: 2025-08-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ustekinumab and Upadacitinib for Induction and Maintenance Therapy in Patients With Refractory Crohn's Disease: A Multicenter, Randomized, Parallel-Controlled Study
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module